Charles Schwab Investment Management Inc Kala Pharmaceuticals, Inc. Transaction History

Charles Schwab Investment Management Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.3 - $1.31 $33,866 - $147,883	-112,888 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$0.61 - $1.84 $3,714 - $11,205	-6,090 Reduced 5.12%	112,888 $156,000
Q2 2021 Aug 16, 2021	BUY	$5.06 - $8.15 $82,219 - $132,429	16,249 Added 15.82%	118,978 $631,000
Q1 2021 May 17, 2021	BUY	$6.24 - $9.58 $20,074 - $30,818	3,217 Added 3.23%	102,729 $693,000
Q3 2020 Nov 13, 2020	SELL	$7.5 - $11.11 $16,987 - $25,164	-2,265 Reduced 2.23%	99,512 $747,000
Q2 2020 Aug 14, 2020	BUY	$8.33 - $13.79 $378,798 - $627,086	45,474 Added 80.77%	101,777 $1.07 Million
Q1 2020 May 15, 2020	BUY	$3.83 - $8.79 $18,759 - $43,053	4,898 Added 9.53%	56,303 $495,000
Q2 2019 Aug 09, 2019	BUY	$4.93 - $8.8 $65,426 - $116,784	13,271 Added 34.8%	51,405 $328,000
Q4 2018 Feb 14, 2019	BUY	$4.29 - $9.94 $62,934 - $145,819	14,670 Added 62.52%	38,134 $187,000
Q3 2018 Nov 13, 2018	BUY	$9.54 - $13.87 $40,678 - $59,141	4,264 Added 22.21%	23,464 $232,000
Q2 2018 Aug 08, 2018	SELL	$13.3 - $17.49 $83,790 - $110,186	-6,300 Reduced 24.71%	19,200 $264,000
Q1 2018 May 07, 2018	BUY	$12.26 - $18.98 $144,668 - $223,964	11,800 Added 86.13%	25,500 $404,000
Q3 2017 Nov 13, 2017	BUY	$19.86 - $26.53 $272,082 - $363,461	13,700	13,700 $313,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $8.67M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.